Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stockwatch: Those That Cannot Be Successful Raise Money

Executive Summary

It struck me last week that that the quote attributed to George Bernard Shaw – "He who can, does. He who cannot, teaches." – can be modified to apply to an increasing cadre of small- and mid-capitalization life science companies. Success for these companies that resonates with investors is either to be acquired or to reach a valuation that is too big to be acquired. The opposite of success is not so easy to define since clinical, regulatory or commercial failure usually means coming back to investors for a bail out.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel